Cite
HARVARD Citation
Gonzalez-Martin, A. et al. (n.d.). 297 Leap-005: evaluating the safety and efficacy of lenvatinib and pembrolizumab in patients previously treated for ovarian cancer, a multi-cohort phase 2 study. International journal of gynecological cancer. pp. A64-A65. [Online].